STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis
Fuente:
Wiley Open Access
Salvato in:
| Autori principali: | , , , , , , , , , , , , |
|---|---|
| Natura: | Artículo Open Access |
| Pubblicazione: |
Wiley
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1867021991065681920 |
|---|---|
| author | Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega |
| author_facet | Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega |
| collection | Wiley Open Access |
| contents | STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega The Journal of Pathology AbstractPeritoneal dialysis (PD) is a widely used kidney replacement therapy for patients with end‐stage kidney disease. Nevertheless, long‐term exposure to PD fluid can damage the peritoneal membrane, leading to ultrafiltration failure and, ultimately, discontinuation of PD. Investigation of the molecular mechanisms underlying this damage is essential for identifying new therapeutic targets to mitigate peritoneal deterioration in PD patients. To this end, we employed RNA sequencing in a preclinical model of peritoneal injury, induced by prolonged chlorhexidine (CHX) exposure, which revealed cytosolic DNA‐sensing signaling as a novel pathway. Next, we demonstrated that key players in this pathway, such as the stimulator of interferon genes (STING) and its downstream signaling effectors (interferon regulatory factor 3, interferon‐stimulated genes, and nuclear factor‐κB signaling), were upregulated in experimental peritoneal damage. Moreover, increased STING expression was observed in human peritoneal biopsies from patients with PD. Subsequent studies in STING‐deficient mice showed reduced proinflammatory gene expression and immune cell infiltration, together with inhibited nuclear factor‐κB pathway activation at both early (10 days) and late (30 days) stages of CHX‐induced peritoneal injury. STING deficiency also reduced peritoneal membrane thickening, fibrosis, and mesothelial‐to‐mesenchymal transition (MMT)‐related changes in advanced CHX‐induced damage. Furthermore, pharmacological inhibition of STING with C‐176 attenuated CHX‐induced peritoneal inflammation. Macrophages were identified as one of the STING‐expressing cell types in the injured peritoneum. Hence, in vitro STING blockade in activated macrophages inhibited MMT in cultured mesothelial cells, suggesting that STING activation in this population may drive peritoneal fibrosis. Additionally, STING deficiency reduced peritoneal inflammation in S. epidermidis‐induced peritonitis and decreased adhesion scores in a postsurgical intra‐abdominal adhesion model. These findings identify STING as a pivotal mediator of peritoneal injury and support its potential as a novel therapeutic target to prevent PD‐associated ultrafiltration failure. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6462 http://creativecommons.org/licenses/by/4.0/ |
| doi_str_mv | 10.1002/path.6462 |
| format | Artículo Open Access |
| id | wiley_oa_10_1002_path_6462 |
| institution | Wiley Open Access |
| license_str_mv | http://creativecommons.org/licenses/by/4.0/ |
| publishDate | 2025 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega The Journal of Pathology STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis Vanessa Marchant Jorge García‐Giménez Guadalupe T González‐Mateo Pilar Sandoval Lucía Tejedor‐Santamaria Sandra Rayego‐Mateos Ricardo Ramos José A Jiménez‐Heffernan Alberto Ortiz Anne‐Catherine Raby Manuel López‐Cabrera Adrián M Ramos Marta Ruiz‐Ortega The Journal of Pathology AbstractPeritoneal dialysis (PD) is a widely used kidney replacement therapy for patients with end‐stage kidney disease. Nevertheless, long‐term exposure to PD fluid can damage the peritoneal membrane, leading to ultrafiltration failure and, ultimately, discontinuation of PD. Investigation of the molecular mechanisms underlying this damage is essential for identifying new therapeutic targets to mitigate peritoneal deterioration in PD patients. To this end, we employed RNA sequencing in a preclinical model of peritoneal injury, induced by prolonged chlorhexidine (CHX) exposure, which revealed cytosolic DNA‐sensing signaling as a novel pathway. Next, we demonstrated that key players in this pathway, such as the stimulator of interferon genes (STING) and its downstream signaling effectors (interferon regulatory factor 3, interferon‐stimulated genes, and nuclear factor‐κB signaling), were upregulated in experimental peritoneal damage. Moreover, increased STING expression was observed in human peritoneal biopsies from patients with PD. Subsequent studies in STING‐deficient mice showed reduced proinflammatory gene expression and immune cell infiltration, together with inhibited nuclear factor‐κB pathway activation at both early (10 days) and late (30 days) stages of CHX‐induced peritoneal injury. STING deficiency also reduced peritoneal membrane thickening, fibrosis, and mesothelial‐to‐mesenchymal transition (MMT)‐related changes in advanced CHX‐induced damage. Furthermore, pharmacological inhibition of STING with C‐176 attenuated CHX‐induced peritoneal inflammation. Macrophages were identified as one of the STING‐expressing cell types in the injured peritoneum. Hence, in vitro STING blockade in activated macrophages inhibited MMT in cultured mesothelial cells, suggesting that STING activation in this population may drive peritoneal fibrosis. Additionally, STING deficiency reduced peritoneal inflammation in S. epidermidis‐induced peritonitis and decreased adhesion scores in a postsurgical intra‐abdominal adhesion model. These findings identify STING as a pivotal mediator of peritoneal injury and support its potential as a novel therapeutic target to prevent PD‐associated ultrafiltration failure. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland. 10.1002/path.6462 http://creativecommons.org/licenses/by/4.0/ |
| title | STING inhibition alleviates experimental peritoneal damage: potential therapeutic relevance for peritoneal dialysis |
| topic | The Journal of Pathology |
| url | https://pathsocjournals.onlinelibrary.wiley.com/doi/10.1002/path.6462 |